Clonazepam all contraindications
Reading File
Finding Sources
Searching the Web
clonazepam all contraindications complete list
Finding Sources
Reading Web Page
https://www.ncbi.nlm.nih.gov/books/NBK556010
Here is a complete overview of clonazepam contraindications, organized by category:
Clonazepam (Klonopin) - All Contraindications
Absolute Contraindications (FDA-Labeled)
Per the 2021 FDA prescribing information, clonazepam is formally contraindicated in:
-
Hypersensitivity to benzodiazepines - Any history of sensitivity to clonazepam or other benzodiazepines (cross-reactivity is possible across the class).
-
Significant liver disease - Clinical or biochemical evidence of significant hepatic impairment. The liver extensively metabolizes clonazepam via CYP3A4; impaired hepatic oxidation leads to drug accumulation, excessive sedation, and respiratory depression. Clonazepam is contraindicated in severe liver disease specifically.
-
Acute narrow-angle (closed-angle) glaucoma - Benzodiazepines can relax the iris and have mild anticholinergic activity, precipitating an acute angle-closure attack. Note: open-angle glaucoma is NOT a contraindication if the patient is on appropriate intraocular pressure therapy.
Boxed Warning (FDA Black Box)
-
Concomitant use with opioids - Combined use of benzodiazepines and opioids significantly increases the risk of profound respiratory depression, sedation, coma, and death. This combination should be avoided; if used together, dose and duration should be minimized with close monitoring.
-
Abuse, misuse, and addiction risk - Clonazepam carries a boxed warning for abuse potential, particularly at supratherapeutic doses or when combined with alcohol, other CNS depressants, or illicit substances.
-
Physical dependence and withdrawal - Abrupt discontinuation can precipitate severe withdrawal reactions including seizures, delirium, and death.
Strong Precautions / Relative Contraindications
These are not absolute contraindications per the FDA label but represent situations where the drug should generally be avoided or used only with extreme caution:
| Condition | Reason |
|---|---|
| Respiratory compromise (COPD, asthma, OSA) | Clonazepam causes respiratory depression and hypersalivation; risk of respiratory failure |
| Renal impairment | Renally excreted; accumulation risk - monitor levels |
| Pregnancy | Risk of neonatal withdrawal syndrome, neonatal CNS depression; teratogenic risk (neonatal flaccidity, respiratory problems); avoid especially in 1st trimester |
| Breastfeeding/lactation | Clonazepam passes into breast milk; neonatal sedation and feeding difficulties |
| Suicidal ideation/history | As an AED, clonazepam carries an FDA-mandated warning for increased suicidal behavior/ideation with all antiepileptic drugs |
| Depression | May worsen depression; paradoxical disinhibition with rage/aggression reported |
| Psychosis | Can worsen or unmask psychotic symptoms |
| Elderly patients | Highly susceptible to falls, paradoxical excitation, cognitive impairment, over-sedation |
| Children with multiple seizure types | Clonazepam can paradoxically worsen or precipitate tonic-clonic seizures in some patients |
| Alcohol use disorder | Additive CNS and respiratory depression; high abuse potential |
| History of substance abuse | High dependence/addiction risk |
| Myasthenia gravis | May worsen neuromuscular blockade and respiratory muscle weakness |
Key Drug Interactions That Constitute Functional Contraindications
- Opioids (boxed warning - see above)
- Other CNS depressants (alcohol, barbiturates, other benzodiazepines, sleep aids, antihistamines, antipsychotics) - additive sedation and respiratory depression
- CYP3A4 inhibitors (fluconazole, ketoconazole, erythromycin, ritonavir) - increase clonazepam plasma levels, raising toxicity risk
- Valproic acid - combination can precipitate absence status epilepticus
- Flumazenil - reversal with flumazenil in epileptic patients on benzodiazepines can provoke rebound seizures
Summary Table
| Category | Contraindication |
|---|---|
| Absolute (FDA) | Benzodiazepine hypersensitivity |
| Absolute (FDA) | Significant/severe liver disease |
| Absolute (FDA) | Acute narrow-angle glaucoma |
| Boxed warning | Concomitant opioid use |
| Relative | Respiratory compromise (COPD, OSA, asthma) |
| Relative | Severe renal impairment |
| Relative | Pregnancy (esp. 1st trimester) |
| Relative | Lactation |
| Relative | Active suicidality/severe depression |
| Relative | Elderly (falls, cognitive impairment) |
| Relative | Substance abuse history |
| Relative | Myasthenia gravis |
| Relative | Multiple seizure-type disorders |
Clinical note: The three formal FDA contraindications are hypersensitivity, significant liver disease, and acute narrow-angle glaucoma. Everything else listed above falls under boxed warnings, strong precautions, or relative contraindications that require clinical judgment.
This is a shared conversation. Sign in to Orris to start your own chat.